Xiaolin Zi
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Pharmacology top 1%
Papers in
-
- Wnt/β-catenin signaling in development and cancer 13
- Cancer-related gene regulation 11
- Epigenetics and DNA Methylation 8
- Ubiquitin and proteasome pathways 6
-
- Prostate Cancer Treatment and Research 8
- Co-authors
- Michaël Pollak (6 shared papers)Rajesh Agarwal (4 shared papers)Anne R. Simoneau (14 shared papers)Bang H. Hoang (28 shared papers)Jun Xie (18 shared papers)Yuqing Zhao (1 shared paper)Yen‐Yu Lu (1 shared paper)Desmond Mascarenhas (1 shared paper)
- Journals
- Cancer Research (17 papers)European Journal of Medicinal Chemistry (4 papers)Molecular Cancer Therapeutics (4 papers)Molecular Cancer (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Xiaolin Zi
104 papers receiving 4.9k citations
Xiaolin Zi's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 1.2k
- Pharmacology 384
- Cancer Research 586
- Complementary and alternative medicine 323
- Molecular Biology 2.7k
Countries citing papers authored by Xiaolin Zi
This map shows the geographic impact of Xiaolin Zi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Zi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Zi more than expected).
Fields of papers citing papers by Xiaolin Zi
This network shows the impact of papers produced by Xiaolin Zi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Zi. The network helps show where Xiaolin Zi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolin Zi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin) Hit paper breakdown → | 2001 | 729 |
| 2 | 1999 | 217 | |
| 3 | 2013 | 203 | |
| 4 | 2005 | 173 | |
| 5 | 2005 | 170 | |
| 6 | 2003 | 166 | |
| 7 | A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. | 1998 | 154 |
| 8 | Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. | 1998 | 149 |
| 9 | 2010 | 119 | |
| 10 | 2010 | 115 | |
| 11 | 2014 | 114 | |
| 12 | Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells. | 2000 | 105 |
| 13 | 2011 | 104 | |
| 14 | 2007 | 102 | |
| 15 | 1997 | 100 | |
| 16 | 2009 | 92 | |
| 17 | 2006 | 90 | |
| 18 | 2010 | 85 | |
| 19 | 2017 | 83 | |
| 20 | 2013 | 74 |
About Xiaolin Zi
Xiaolin Zi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Complementary and alternative medicine and Cancer Research, having authored 106 papers that have together received 5.0k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (13 papers), Cancer-related Molecular Pathways (13 papers), Cancer-related gene regulation (11 papers), Medicinal Plant Extracts Effects (11 papers), Epigenetics and DNA Methylation (8 papers), Prostate Cancer Treatment and Research (8 papers), Cancer, Lipids, and Metabolism (8 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Oncology (1.2k citations), Pharmacology (384 citations), Cancer Research (586 citations), Complementary and alternative medicine (323 citations) and Molecular Biology (2.7k citations). Xiaolin Zi has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Michaël Pollak, Rajesh Agarwal, Anne R. Simoneau, Bang H. Hoang, Jun Xie, Yuqing Zhao, Yen‐Yu Lu, Desmond Mascarenhas, Yi Guo and Xuesen Li. Their work appears in journals such as Cancer Research, European Journal of Medicinal Chemistry, Molecular Cancer Therapeutics, Molecular Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.